Evidence map›Paper›PMID 38836055›Full record

ArticleFrontiers in cellular and infection microbiology2024

Efficacy of omadacycline in the treatment of

Yao Wang, Shui-Min Yi, Si-Min Huang, Wei-Xin Xu, Yi-Wen Wei, Qiang Qu, Jian Qu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Frontiers in microbiology · 2026
    Article
  2. Case Report: CavitaryFrontiers in medicine · 2026
    Article
  3. A case of severeRespiratory medicine case reports · 2026
    Article
  4. Omadacycline successfully treated severeFrontiers in pharmacology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yao Wang *Department of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.
Shui-Min Yi *Department of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.
Si-Min Huang *Department of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.
Wei-Xin XuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.
Yi-Wen WeiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.
Qiang QuDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Jian QuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsLegionella pneumophilaLegionnaires' DiseaseTetracyclinesCommunity-Acquired InfectionsHumansMaleMiddle AgedMoxifloxacinTreatment OutcomeAnti-Bacterial AgentsMoxifloxacinomadacyclineTetracyclinesLegionellaLegionella pneumoniamoxifloxacinnovel tetracyclineomadacycline

Identifiers

PMID38836055
PMCPMC11148271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.